ÂÜÀòÂÒÂ×

Christopher Browne has a diverse work experience spanning over two decades. Christopher is currently serving as a Principal Scientist at Kymera Therapeutics since January 2023. Prior to this, they held the role of Senior Scientist at the same company from January 2021 to January 2023.

Before joining Kymera Therapeutics, Christopher worked as a Senior Scientist at AstraZeneca from 2019 to 2021. Christopher was responsible for contributing to research projects and conducting scientific investigations.

From 2014 to 2019, Christopher served as a Postdoctoral Research Fellow at the Dana-Farber Cancer Institute. During this time, they conducted research related to cancer and contributed to scientific publications.

Christopher's academic background includes working as a PhD Student in Biochemistry at Vanderbilt University from 2006 to 2013. Their research at Vanderbilt focused on the link between sphingolipid synthesis and protein translation factor localization, with implications for cancer progression and neurodegenerative disorders. Additionally, they managed a team of graduate students, developed new methods for lipid quantification, and generated interaction maps.

During their undergraduate years at the University of Tennessee from 2003 to 2006, Christopher gained experience as an Undergraduate Research Assistant. Christopher conducted research on protein translocation across the inner membrane of the chloroplast and supported graduate students and research associates in the lab.

Important early experiences in Christopher's career include working as a Summer Research Assistant at Vanderbilt University in 2005, where they collaborated on studying protein expression in precancerous lesions and identified potential biomarkers for early metastasis in neuroendocrine prostate cancer. Additionally, they worked as a Teaching Assistant in a Proteomics Course at Cold Spring Harbor Laboratory in 2010.

As a high school student, Christopher worked as a Cashier at McDonald's for a brief period in 2002.

Overall, Christopher Browne's work experience encompasses various research positions in the field of biochemistry and pharmaceuticals, showcasing their skills in scientific research, project management, and team leadership.

Christopher Browne earned a Bachelor of Science (B.S.) degree in Biochemistry, Cellular and Molecular Biology from the University of Tennessee, Knoxville, from 2002 to 2006. Christopher then pursued a Doctor of Philosophy (PhD) in Biochemistry at Vanderbilt University from 2006 to 2013.